Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion

International Journal of Cancer

Volumn 127, Issue 6, 2010, Pages 1283-1294

  D'Eliseo, Donatella ^a,b   Pisu, Paola ^b,c   Romano, Chiara ^b,c   Tubaro, Andrea ^d   De Nunzio, Cosimo ^d   Morrone, Stefania ^c   Santoni, Angela ^b,c   Stoppacciaro, Antonella ^c   Velotti, Francesca ^a,b  

^a UNIVERSITY OF TUSCIA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Epithelial mesenchymal transition; Extracellular matrix; Granzyme B; Invasion; Urothelial carcinoma

Indexed keywords

GRANZYME B; NERVE CELL ADHESION MOLECULE; PERFORIN; TRANSCRIPTION FACTOR SNAIL; VITRONECTIN;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UROTHELIUM CARCINOMA;

BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANZYMES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; URINARY BLADDER NEOPLASMS;

EID: 77955621496     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25135     Document Type: Article

References (52)

1. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. World Health Organization (WHO) classification of tumors of the urinary system and male genital organs. Lyon: IARC Press, 2004. 90-92.
2. Black PC, Dinney CPN. Bladder cancer angiogenesis and metastatis-translation from murine model to clinical trial. Cancer Metastatis Rev 2007;26:623-634.
3. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74. (Pubitemid 37328786)
4. O'Brien P, O'Connor BF. Seprase: an overview of an important matrix serine protease. Biochim Biophys Acta 2008;1784:1130-45.
5. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002;20:323-70.
6. Bleackley RC. A molecular view of cytotoxic T lymphocyte induced killing. Biochem Cell Biol 2005;83:747-51.
7. Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 2008;26:389-420. (Pubitemid 351611623)
8. Cullen SP, Martin S. Mechanisms of granule-dependent killing. Cell Death Differ 2008;15:251-62.
9. Beseničar MP, Metkar S, Wang B, Froelich CJ, Anderluh G. Granzyme B translocates across the lipid membrane only in the presence of lytic agents. Biochem Biophys Res Commun 2008;371:391-4.
10. Kaiserman D, Bird CH, Sun J, Matthews A, Ung K, Whisstock JC, Thompson PE, Trapani JA, Bird PI. The major human and mouse granzymes are structurally and functionally divergent. J Cell Biol 2006;17:619-30. (Pubitemid 44790615)
11. Casciola-Rosen L, Garcia-Calvo M, Bull HG, Becker JW, Hines T, Thornberry NA, Rosen A. Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the bid pathway. J Biol Chem 2007;282:4545-52. (Pubitemid 47100932)
12. Cullen SP, Adrain C, Lüthi AU, Duriez PJ, Martin SJ. Human and murine granzyme B exhibit divergent substrate preferences. J Cell Biol 2007;176:435-44. (Pubitemid 46257271)
13. Romero V, Andrade F. Non-apoptotic functions of granzymes. Tissue Antigens 2008;71:409-16.
14. Choy JC, Hung VH, Hunter AL, Cheung PK, Motyka B, Goping IS, Sawchuk T, Bleackley RC, Podor TJ, McManus BM, Granville DJ. Granzyme B induces smooth muscle cell apoptosis in the absence of perforin: involvement of extracellular matrix degradation. Arterioscler Thromb Vasc Biol 2004;24:2245-50.
15. Buzza MS, Zamurs L, Sun J, Bird CH, Smith AI, Trapani JA, Froelich CJ, Nice EC, Bird PI. Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin and laminin. J Biol Chem 2005;280:23549-558. (Pubitemid 40884833)
16. Buzza MS, Bird PI. Extracellular granzymes: current perspectives. Biol Chem 2006;387:827-37.
17. Froelich CJ, Pardo J, Simon MM. Granule-associated serine proteases: granzymes might not just be killer proteases. Trends Immunol 2009;30:117-23.
18. Garcia-Sanz JA, Plaetinck G, Velotti F, Masson D, Tschopp J, MacDonald HR, Nabholz M. Perforin is present only in normal activated Lyt2+ T lymphocytes and not in L3T4+ cells, but the serine protease granzyme A is made by both subsets. EMBO J 1987;6:933-8.
19. Berthou C, Marolleau JP, Lafaurie C, Soulié A, Dal Cortivo L, Bourge JF, Benbunan M, Sasportes M. Granzyme B and perforin lytic proteins are expressed in CD34+ peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor. Blood 1995;86:3500-06.
20. Tordjmann T, Soulie A, Guettier C, Schmidt M, Berthou C, Beaugrand M, Sasportes M. Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis. Liver 1998;18:391-7. (Pubitemid 28550323)
21. Rissoan MC, Duhen T, Bridon JM, Bendriss-Vermare N, Péronne C, de Saint Vis B, Brière F, Bates EE. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7. Eph-B1, granzyme. B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 2002;100:3295-303.
22. Tschopp CM, Spiegl N, Didichenko S, Lutmann W, Julius P, Virchow JC, Hack CE, Dahinden CA. Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. Blood 2006;108:2290-9. (Pubitemid 44497512)
23. Strik MC, de Koning PJ, Kleijmeer MJ, Bladergroen BA, Wolbink AM, Griffith JM, Wouters D, Fukuoka Y, Schwartz LB, Hack CE, van Ham SM, Kummer JA. Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. Mol Immunol 2007;44:3462-72. (Pubitemid 46754451)
24. Kim WJ, Kim H, Suk K, Lee WH. Macrophages express granzyme B in the lesion areas of atherosclerosis and rheumatoid arthritis. Immunol Lett 2007;111:57-65. (Pubitemid 47017480)
25. Bruno AP, Lautier D, d'Orgeix AT, Laurent G, Quillet-Mary A. Acute myeloblastic leukemic cells acquire cellular cytotoxicity under genotoxic stress: implication of granzyme B and perforin. Blood 2000;96:1914-20.
26. Jahrsdörfer B, Blackwell SE, Wooldridge JE, Huang J, Andreski MW, Jacobus LS, Taylor CM, Weiner GJ. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21- based activation. Blood 2006;108:2712-9.
27. Berthou C, Michel L, Soulié A, Jean-Louis F, Flageul B, Dubertret L, Sigaux F, Zhang Y, Sasportes M. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense. J Immunol 1997;159:5293-300. (Pubitemid 127470055)
28. Hernandez-Pigeon H, Jean C, Charruyer A, Haure MJ, Baudouin C, Charveron M, Quillet-Mary A, Laurent G. Human keratinocytes acquire cellular cytotoxicity under UV-B irradiation. Implication of granzyme B and perforin. J Biol Chem 2006;281:13525-32. (Pubitemid 43855265)
29. Hernandez-Pigeon H, Jean C, Charruyer A, Haure MJ, Baudouin C, Charveron M, Quillet-Mary A, Laurent G UVA induces granzyme B in human keratinocytes through MIF: implication in extracellular matrix remodeling. J Biol Chem 2007;282:8157-64. (Pubitemid 47093610)
30. Hirst CE, Buzza MS, Sutton VR, Trapani JA, Loveland KL, Bird PI. Perforinin-dependent expression of granzyme B and proteinase inhibitor 9 in human testis and placenta suggests a role for granzyme B-mediated proteolysis in reproduction. Mol Hum Reprod 2001;7:1133-42.
31. Sasson R, Amsterdam. A Pleiotropic antiapoptotic activity of glucocorticoids in ovarian follicular cells. Biochem Pharmacol 2003;66:1393-401.
32. Horiuchi K, Saito S, Sasaki R, Tomatsu T, Toyama Y. Expression of granzyme B in human chondrocytes. J Rheumatol 2003;30:1799-810.
33. Hu SX, Wang S, Wang JP, Millis GB, Zhou Y, Xu H-J. Expression of endogenous granzyme B in a subset of human primary breast carcinomas. Br J Cancer 2003;89:135-9. (Pubitemid 36897949)
34. Chopin D, Barei-Moniri R, Maillé P, Le Frère-Belda MA, Muscatelli-Groux B, Merendino N, Lecerf L, Stoppacciaro A, Velotti F. Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression. Am J Pathol 2003;162:1139-49. (Pubitemid 36350659)
35. Trapani JA, Browne KA, Dawson M, Smith MJ. Immunopurification of functional Aspase (natural killer cell granzyme B) using a monoclonal antibody. Biochem Biophys Res Commun 1993;195:910-20. (Pubitemid 23280502)
36. Spaeny-Dekking EH, Hanna WL, Wolbink AM, Wever PC, Kummer JA, Swaak AJ, Middeldorp JM, Huisman HG, Froelich CJ, Hack CE. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol 1998;160:3610-16.
37. Zuber B, Levitsky V, Jönsson G, Paulie S, Samarina A, Grundström S, Metkar S, Norell H, Callender GG, Froelich C, Ahlborg N. Detection of human perforin by ELISpot and ELISA: ex vivo identification of virus-specific cells. J Immunol Methods 2005;302:13-25. (Pubitemid 41111869)
38. Hameed A, Olsen KJ, Cheng L, Fox WMD, Hruban RH, Podack ER. Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody. Am J Pathol 1992;140:1025-30.
39. Kummer JA, Kamp AM, van Katwijk M, Brakenhoff JP, Radosević K, van Leeuwen AM, Borst J, Verweij CL, Hack CE. Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B showing cross reactions with the natural proteins. J Immunol Methods 1993;163:77-83. (Pubitemid 23213032)
40. Velotti F, Palmieri G, D'Ambrosio D, Piccoli M, Frati L, Santoni A. Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer cells (NK) and lymphokine-activated killer cells with NK phenotype (LAK-NK). Eur J Immunol 1992;22:1049-53.
41. Mahrus S, Craik CS. Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells. Chem Biol 2005;12:567-77. (Pubitemid 40727931)
42. Odake S, Kam CM, Narasimhan L, Poe M, Blake JT, Krahenbuhl O, Tschopp J, Powers JC. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry 1991;30:2217-27.
43. Thiery JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-42.
44. Lipponen PK, Eskelinen MJ. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J Cancer Res Clin Oncol 1995;121:303-8.
45. Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, Bittard H. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res 2006;12:2780-7. (Pubitemid 43752117)
46. Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA, Summerhayes IC. Identification and prognostic significance of an epithelialmesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 2007;13:1685-89.
47. Bryan RT, Atherfold PA, Yeo Y, Jones LJ, Harrison RF, Wallace DM, Jankowski JA. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies. J Pathol 2008;215:184-94. (Pubitemid 351786037)
48. Inayat-Hussain SH, McGuinness SM, Johansson R, Lundstrom J, Ross D. Caspase-dependent and -independent mechanisms in apoptosis induced by hydroquinone and catechol metabolites of remoxipride in HL-60 cells. Chem Biol Interact 2000;128:51-63.
49. Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D, Simmons DL, Akbar AN, Lord JM, Salmon M. RGD peptides induce apoptosis by direct caspase-3 activation. Nature 1999;397:534-9. (Pubitemid 29093253)
50. Doucey MA, Legler DF, Faroudi M, Boucheron N, Baumgaertner P, Naeher D, Cebecauer M, Hudrisier D, Rüegg C, Palmer E, Valitutti S, Bron C, et al. The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. J Biol Chem 2003;278:26983-91.
51. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6:24-37. (Pubitemid 43053650)
52. Triantafilou K, Takada Y, Triantafilou M. Mechanisms of integrin-mediated virus attachment and internalization process. Crit Rev Immunol 2001;21:311-22. (Pubitemid 34208439)